Tension-type headache

Expert Review of Neurotherapeutics

Volumn 8, Issue 5, 2008, Pages 839-853

  Speciali, José Geraldo ^a   Eckeli, Alan Luiz ^a   Dach, Fabíola ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Comorbidities; Pathophysiology; Psychopathology; Tension type headache; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; BOTULINUM TOXIN A; CAFFEINE; CHLORPROMAZINE; CLOMIPRAMINE; DICLOFENAC POTASSIUM; DIPYRONE; DOXEPIN; FLUOXETINE; IBUPROFEN; KETOPROFEN; KETOROLAC; MAPROTILINE; MIANSERIN; MIRTAZAPINE; NAPROXEN; NORTRIPTYLINE; PARACETAMOL; PAROXETINE; PLACEBO; PROTRIPTYLINE; SULPIRIDE; TIZANIDINE; VENLAFAXINE;

AGRANULOCYTOSIS; ANOREXIA; ANXIETY; BEDTIME DOSAGE; CHIROPRACTIC; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONSTIPATION; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DRUG DOSE ESCALATION; ELECTROSTIMULATION THERAPY; HUMAN; HYPOTENSION; INSOMNIA; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LOW DRUG DOSE; MENTAL DISEASE; MIGRAINE; MONOTHERAPY; MORNING DOSAGE; PATHOPHYSIOLOGY; PHYSIOTHERAPY; RECOMMENDED DRUG DOSE; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; STOMACH HEMORRHAGE; STOMACH PAIN; TENSION HEADACHE; TRANSCUTANEOUS NERVE STIMULATION; WEIGHT GAIN; XEROSTOMIA;

ANALGESICS; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; TENSION-TYPE HEADACHE; TREATMENT OUTCOME;

EID: 43249107337     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.5.839     Document Type: Review

References (159)

1. The International Classification of Headache Disorders (2nd Edition). Cephalalgia 24(Suppl. 1), 9-160 (2004). •• All professionals who devote themselves to the study of headache should use these diagnostic criteria, so the results and conclusions of the investigations carried out can be universally understood and applied.
2. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur. J. Epidemiol. 20, 243-249 (2005).
3. Stovner L, Hagen K, Jensen R et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27, 193-210 (2007).
4. Ho KH, Ong BK. A community-based study of headache diagnosis and prevalence in Singapore. Cephalalgia 23, 6-13 (2003).
5. Lavados PM, Tenhamm E. Epidemiology of tension-type headache in Santiago, Chile: a prevalence study. Cephalalgia 18, 552-558 (1998).
6. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 279, 381-383 (1998).
7. Gobel H, Petersen-Braun M, Soyka D. The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 14, 97-106 (1994).
8. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Incidence of primary headache: a Danish epidemiologic follow-up study. Am. J. Epidemiol. 161, 1066-1073 (2005).
9. Boardman HF, Thomas E, Croft PR, Millson DS. Epidemiology of headache in an English district. Cephalalgia 23, 129-137 (2003).
10. Rasmussen BK. Migraine and tension-type headache in a general population: psychosocial factors. Int. J. Epidemiol. 21, 1138-1143 (1992).
11. Laurell K, Larsson B, Eeg-Olofsson O. Prevalence of headache in Swedish schoolchildren, with a focus on tension-type headache. Cephalalgia 24, 380-388 (2004).
12. Barea LM, Tannhauser M, Rotta NT. An epidemiologic study of headache among children and adolescents of southern Brazil. Cephalalgia 16, 545-549 (1996).
13. Anttila P, Metsahonkala L, Aromaa M et al. Determinants of tension-type headache in children. Cephalalgia 22, 401-408 (2002).
14. Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J. Epidemiol. Community Health 46, 443-446 (1992).
15. Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J. Occup. Environ. Med. 39, 320-327 (1997).
16. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can. J. Neurol. Sci. 20, 131-137 (1993).
17. Silva HM Jr, Garbelini RP, Teixeira SO, Bordini CA, Speciali JG. Effect of episodic tension-type headache on the health-related quality of life in employees of a Brazilian public hospital. Arq. Neuropsiquiatr. 62, 769-773 (2004).
18. Wang SJ, Fuh JL, Lu SR, Juang KD. Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain 89, 285-292 (2001).
19. Bigal ME, Bigal JM, Betti M, Bordini CA, Speciali JG. Evaluation of the impact of migraine and episodic tension-type headache on the quality of life and performance of a university student population. Headache 41, 710-719 (2001).
20. Lavados PM, Tenhamm E. Consulting behaviour in migraine and tension-type headache sufferers: a population survey in Santiago, Chile. Cephalalgia 21, 733-737 (2001).
21. Karli N, Zarifoglu M, Ertafs M et al. Economic impact of primary headaches in Turkey: a university hospital based study: part II. J. Headache Pain 7, 75-82 (2006).
22. Rasmussen BK. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 53, 65-72 (1993).
23. Jensen R, Rasmussen BK, Pedersen B, Olesen J. Muscle tenderness and pressure pain thresholds in headache. A population study. Pain 52, 193-199 (1993).
24. Langemark M, Olesen J. Pericranial tenderness in tension headache. A blind, controlled study. Cephalalgia 7, 249-255 (1987).
25. Bendtsen L, Jensen R, Olesen J. Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch. Neurol. 53, 373-376 (1996).
26. Ashina S, Bendtsen L, Ashina M, Magerl W, Jensen R. Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia 26, 940-948 (2006).
27. Christensen MB, Bendtsen L, Ashina M, Jensen R. Experimental induction of muscle tenderness and headache in tension-type headache patients. Cephalalgia 25, 1061-1067 (2005).
28. Davidoff RA. Trigger points and myofascial pain: toward understanding how they affect headaches. Cephalalgia 18, 436-448 (1998).
29. Masdeu JC, Drayer BP, Anderson RE et al. Atraumatic isolated headache - when to image. American College of Radiology. ACR Appropriateness Criteria. Radiology 215(Suppl.) 487-493 (2000).
30. Sempere AP, Porta-Etessam J, Medrano V et al. Neuroimaging in the evaluation of patients with non-acute headache. Cephalalgia 25, 30-35 (2005).
31. Frishberg BM. Neuroimaging in presumed primary headache disorders. Semin. Neurol. 17, 373-382 (1997).
32. Valenca MM, Valenca LP, Menezes TL. Computed tomography scan of the head in patients with migraine or tension-type headache. Arq. Neuropsiquiatr. 60, 542-547 (2002).
33. Brandes AA, Compostella A, Blatt V, Tosoni A. Glioblastoma in the elderly: current and future trends. Crit. Rev. Oncol. Hematol. 60, 256-266 (2006).
34. Lin NU, Winer EP. Brain metastases: the HER2 paradigm. Clin. Cancer Res. 13, 1648-1655 (2007).
35. Schwedt TJ, Matharu MS, Dodick DW. Thunderclap headache. Lancet Neurol. 5, 621-631 (2006).
36. Matharu MS, Schwedt TJ, Dodick DW. Thunderclap headache: an approach to a neurologic emergency. Curr. Neurol. Neurosci. Rep. 7, 101-109 (2007).
37. Schwedt TJ. Clinical spectrum of thunderclap headache. Expert Rev. Neurother. 7, 1135-1144 (2007).
38. Schankin CJ, Ferrari U, Reinisch VM, Birnbaum T, Goldbrunner R, Straube A. Characteristics of brain tumour-associated headache. Cephalalgia 27, 904-911 (2007).
39. Dowson AJ, Dodick DW, Limmroth V. Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis. CNS Drugs 19, 483-497 (2005).
40. Limmroth V, Katsarava Z. Medication overuse headache. Curr. Opin. Neurol. 17, 301-306 (2004).
41. Sobri M, Lamont AC, Alias NA, Win MN. Red flags in patients presenting with headache: clinical indications for neuroimaging. Br. J. Radiol. 76, 532-535 (2003).
42. Khandelwal S, Miller CD. Distinguishing dural sinus thrombosis from benign intracranial hypertension. Emerg. Med. J. 21, 245-247 (2004).
43. Ball AK, Clarke CE. Idiopathic intracranial hypertension. Lancet Neurol. 5, 433-442 (2006).
44. Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia 26, 384-399 (2006).
45. van Vliet JA, Eekers PJ, Haan J, Ferrari MD. Evaluating the IHS criteria for cluster headache - a comparison between patients meeting all criteria and patients failing one criterion. Cephalalgia 26, 241-245 (2006).
46. Evers S, Goadsby PJ. Hypnic headache: clinical features, pathophysiology, and treatment. Neurology 60, 905-909 (2003).
47. Svensson P. Muscle pain in the head: overlap between temporomandibular disorders and tension-type headaches. Curr. Opin. Neurol. 20, 320-325 (2007).
48. Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology 43, 1678-1683 (1993).
49. Ulrich V, Russell MB, Jensen R, Olesen J. A comparison of tension-type headache in migraineurs and in non-migraineurs: a population-based study. Pain 67, 501-506 (1996).
50. Russell MB, Levi N, Saltyte-Benth J, Fenger K. Tension-type headache in adolescents and adults: a population based study of 33,764 twins. Eur. J. Epidemiol. 21, 153-160 (2006).
51. Russell MB. Tension-type headache in 40-year-olds: a Danish population-based sample of 4000. J. Headache Pain 6, 441-447 (2005).
52. Matta AP, Moreira Filho PF. [Depressive symptoms and anxiety in patients with chronic and episodic tension-type headache]. Arq. Neuropsiquiatr. 61, 991-994 (2003).
53. Guidetti V, Galli F, Fabrizi P et al. Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 18, 455-462 (1998).
54. Wang SJ, Liu HC, Fuh JL, Liu CY, Wang PN, Lu SR. Comorbidity of headaches and depression in the elderly. Pain 82, 239-243 (1999).
55. Puca F, Genco S, Prudenzano MP et al. Psychiatric comorbidity and psychosocial stress in patients with tenmsion-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia 19, 159-164 (1999).
56. Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51, 8-19 (1994).
57. Janke EA, Holroyd KA, Romanek K. Depression increases onset of tension-type headache following laboratory stress. Pain 111, 230-238 (2004).
58. Baskin SM, Lipchik GL, Smitherman TA. Mood and anxiety disorders in chronic headache. Headache 46(Suppl. 3), S76-S87 (2006). •• This paper deals with the main mood and anxiety disorders related to migraine, tension-type headache (TTH) and chronic headaches. It also contains the diagnoses, treatments and implications of these conditions in the headaches mentioned.
59. Martin PR. Tension headache: psychophysiological investigation and treatment. J. Psychosom. Res. 22, 389-399 (1978).
60. Bakal DA, Kaganov JA. Muscle contraction and migraine headache: psychophysiologic comparison. Headache 17, 208-215 (1977).
61. Krabbe AA, Olesen J. Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms. Pain 8, 253-259 (1980).
62. Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence of cervical and trigeminal sensory afferents. Curr. Pain Headache Rep. 7, 377-383 (2003).
63. Myofascial Pain and Dysfunction: the Trigger Point Manual (2nd Edition). Simons DG, Travel J, Simons LS (Eds). Lippincott Williams & Wilkins, Baltimore, MD, USA (1999).
64. Jensen R. Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 19, 602-621 (1999).
65. Fernandez-de-Las-Penas C, Ge HY, Arendt-Nielsen L, Cuadrado ML, Pareja JA. Referred pain from trapezius muscle trigger points shares similar characteristics with chronic tension type headache. Eur. J. Pain 11, 475-482 (2007).
66. Fernandez-de-las-Penas C, Alonso-Blanco C, Cuadrado ML, Gerwin RD, Pareja JA. Trigger points in the suboccipital muscles and forward head posture in tension-type headache. Headache 46, 454-460 (2006).
67. Fernandez-de-Las-Penas C, Alonso-Blanco C, Cuadrado ML, Gerwin RD, Pareja JA. Myofascial trigger points and their relationship to headache clinical parameters in chronic tension-type headache. Headache 46, 1264-1272 (2006).
68. Schmidt-Hansen PT, Svensson P, Bendtsen L, Graven-Nielsen T, Bach FW. Increased muscle pain sensitivity in patients with tension-type headache. Pain 129, 113-121 (2007).
69. Simons DG, Hong CZ, Simons LS. Endplate potentials are common to midfiber myofacial trigger points. Am. J. Phys Med. Rehabil. 81, 212-222 (2002).
70. Mense S. Nociception from skeletal muscle in relation to clinical muscle pain. Pain 54, 241-289 (1993).
71. Schmidt RF. Sensitization of peripheral nocisensors in muscle. In: Tension-Type Headache: Classification, Mechanisms, and Treatment. Olesen J, Schoenen J (Eds). Raven Press, NY, USA, 47-59 (1993).
72. Ashina M, Stallknecht B, Bendtsen L et al. Tender points are not sites of ongoing inflammation -in vivo evidence in patients with chronic tension-type headache. Cephalalgia 23, 109-116 (2003).
73. Bendtsen L. Central sensitization in tension-type headache - possible pathophysiological mechanisms. Cephalalgia 20, 486-508 (2000). •• Analyzes in detail the peripheral and central pathophysiological mechanisms of TTH, especially central sensitization.
74. Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain 118, 215-223 (2005).
75. Schmidt-Wilcke T, Leinisch E, Straube A et al. Gray matter decrease in patients with chronic tension type headache. Neurology 65, 1483-1486 (2005).
76. Schoenen J, Jamart B, Gerard P, Lenarduzzi P, Delwaide PJ. Exteroceptive suppression of temporalis muscle activity in chronic headache. Neurology 37, 1834-1836 (1987).
77. Nardone R, Tezzon F. The trigeminocervical reflex in tension-type headache. Eur. J. Neurol. 10, 307-312 (2003).
78. Bendtsen L, Schoenen J. Synthesis of tension-type headache mechanisms. In: The Headaches (3rd Edition). Olesen J, Goadsby PJ, Ramadan N et al (Eds). Lippincott Williams & Wilkins, PA, USA 677-681 (2006).
79. Ashina M. Pathophysiology of tension-type headache: potential drug targets. CNS Neurol. Disord. Drug Targets 6, 238-239 (2007).
80. Andrasik F, Wittrock DA, Passchier J. Psychological mechanisms of tension-type headaches. In: The Headaches (3rd Edition). Olesen J, Goadsby PJ, Ramadan N et al (Eds). Lippincott Williams & Wilkins, PA, USA 663-667 (2006).
81. Jensen R, Olesen J. Tension-type headache: an update on mechanisms and treatment. Curr. Opin. Neurol. 13, 285-289 (2000). • The authors comment on the lack of interest in studying TTH on the part of investigators and predict a great advance in the understanding of the physiopathological mechanisms of the condition and in the development of specific treatments in the near future.
82. Russell MB, Saltyte-Benth J, Levi N. Are infrequent episodic, frequent episodic and chronic tension-type headache inherited? A population-based study of 11 199 twin pairs. J. Headache Pain 7, 119-126 (2006).
83. Russell MB. Genetics of tension-type headache. J. Headache Pain 8, 71-76 (2007).
84. Ulrich V, Gervil M, Olesen J. The relative influence of environment and genes in episodic tension-type headache. Neurology 62, 2065-2069 (2004). • Through a review of the literature, it is concluded that frequent episodic TTH (ETTH) and chronic TTH are caused by a combination of genetic and environmental factors, while infrequent ETTH is mainly caused by environmental factors.
85. Russell MB, Ostergaard S, Bendtsen L, Olesen J. Familial occurrence of chronic tension-type headache. Cephalalgia 19, 207-210 (1999).
86. Russell MB. Genetics in primary headaches. J. Headache Pain 8, 190-195 (2007).
87. Russell MB, Levi N, Kaprio J. Genetics of tension-type headache: a population based twin study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144(8), 982-986 (2007).
88. Eccleston C, Yorke L, Morley S, Williams AC, Mastroyannopoulou K. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst. Rev. (1), CD003968 (2003). •• A systematic review of psychological therapies (relaxation techniques and cognitive-behavioral therapy) in the management of chronic headaches in children and adolescents.
89. Penzien DB, Rains JC, Andrasik F. Behavioral management of recurrent headache: three decades of experience and empiricism. Appl. Psychophysiol. Biofeedback 27, 163-181 (2002).
90. Andrasik F. Behavioral treatment approaches to chronic headache. Neurol. Sci. 24(Suppl. 2), S80-S85 (2003).
91. Devineni T, Blanchard EB. A randomized controlled trial of an internet-based treatment for chronic headache. Behav. Res. Ther. 43, 277-292 (2005).
92. Bussone G, Grazzi L, D'Amico D, Leone M, Andrasik F. Biofeedback-assisted relaxation training for young adolescents with tension-type headache: a controlled study. Cephalalgia 18, 463-467 (1998).
93. McGrady AV, Andrasik F, Davies T et al. Psychophysiologic therapy for chronic headache in primary care. Prim. Care Companion J. Clin. Psychiatry 1, 96-102 (1999).
94. Arena JG, Bruno GM, Hannah SL, Meador KJ. A comparison of frontal electromyographic biofeedback training, trapezius electromyographic biofeedback training, and progressive muscle relaxation therapy in the treatment of tension headache. Headache 35, 411-419 (1995).
95. Holroyd KA, Penzien DB. Psychosocial interventions in the management of recurrent headache disorders. 1.Overview and effectiveness. Behav. Med. 20, 53-63 (1994).
96. Penzien DB, Rains JC, Lipchik GL, Creer TL. Behavioral interventions for tension-type headache: overview of current therapies and recommendation for a self-management model for chronic headache. Curr. Pain Headache Rep. 8, 489-499 (2004).
97. Tavola T, Gala C, Conte G, Invernizzi G. Traditional Chinese acupuncture in tension-type headache: a controlled study. Pain 48, 325-329 (1992).
98. Melchart D, Streng A, Hoppe A et al. Acupuncture in patients with tension-type headache: randomised controlled trial. Br. Med. J. 331, 376-382 (2005).
99. White AR, Resch KL, Chan JC et al. Acupuncture for episodic tension-type headache: a multicentre randomized controlled trial. Cephalalgia 20, 632-637 (2000).
100. Melchart D, Linde K, Fischer P et al. Acupuncture for idiopathic headache. Cochrane Database Syst. Rev. (1), CD001218 (2001).
101. Lenssinck ML, Damen L, Verhagen AP, Berger MY, Passchier J, Koes BW. The effectiveness of physiotherapy and manipulation in patients with tension-type headache: a systematic review. Pain 112, 381-388 (2004).
102. Bronfort G, Nilsson N, Haas M et al. Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst. Rev. (3), CD001878 (2004).
103. Biondi DM. Physical treatments for headache: a structured review. Headache 45, 738-746 (2005).
104. Soderberg E, Carlsson J, Stener-Victorin E. Chronic tension-type headache treated with acupuncture, physical training and relaxation training. Between-group differences. Cephalalgia 26, 1320-1329 (2006).
105. van Ettekoven H, Lucas C. Efficacy of physiotherapy including a craniocervical training programme for tension-type headache: a randomized clinical trial. Cephalalgia 26, 983-991 (2006).
106. Farinelli I, Martelletti P. Aspirin and tension-type headache. J. Headache Pain 8, 49-55 (2007).
107. Martinez-Martin P, Raffaelli E Jr, Titus F et al. Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 21, 604-610 (2001).
108. Nebe J, Heier M, Diener HC. Low-dose ibuprofen in self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo. Cephalalgia 15, 531-535 (1995).
109. Steiner TJ, Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 23, 59-66 (2003).
110. Prior MJ, Cooper KM, May LG, Bowen DL. Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, doubleblind, placebo-controlled trial. Cephalalgia 22, 740-748 (2002).
111. Dahlof CG, Jacobs LD. Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache. Cephalalgia 16, 117-123 (1996).
112. Ramacciotti AS, Soares BG, Atallah AN. Dipyrone for acute primary headaches. Cochrane Database Syst. Rev. (2), CD004842 (2007).
113. Packman B, Packman E, Doyle G et al. Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache 40, 561-567 (2000).
114. Diamond S, Balm TK, Freitag FG. Ibuprofen plus caffeine in the treatment of tension-type headache. Clin. Pharmacol. Ther. 68, 312-319 (2000).
115. Lange R, Lentz R. Comparison ketoprofen, ibuprofen and naproxen sodium in the treatment of tension-type headache. Drugs Exp. Clin. Res. 21, 89-96 (1995).
116. Kubitzek F, Ziegler G, Gold MS, Liu JM, Ionescu E. Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur. J. Pain 7, 155-162 (2003).
117. Harden RN, Rogers D, Fink K, Gracely RH. Controlled trial of ketorolac in tension-type headache. Neurology 50, 507-509 (1998).
118. Diamond S, Freitag FG. The use of ibuprofen plus caffeine to treat tension-type headache. Curr. Pain Headache Rep. 5, 472-478 (2001).
119. Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT. Caffeine as an analgesic adjuvant in tension headache. Clin. Pharmacol. Ther. 56, 576-586 (1994).
120. Bigal ME, Bordini CA, Speciali JG. Intravenous dipyrone for the acute treatment of episodic tension-type headache: a randomized, placebo-controlled, double-blind study. Braz. J. Med. Biol. Res. 35, 1139-1145 (2002).
121. Bigal ME, Bordini CA, Speciali JG. [Headache treatment in an emergency unit of the city of Ribeirao Preto, Brazil]. Arq. Neuropsiquiatr. 57, 813-819 (1999).
122. Bigal ME, Bordini CA, Speciali JG. Intravenous chlorpromazine in the acute treatment of episodic tension-type headache: a randomized, placebo controlled, double-blind study. Arq. Neuropsiquiatr. 60, 537-541 (2002). •• Shows the beneficial effect of a neuroleptic in the acute treatment of TTH.
123. Silberstein SD, Olesen J, Bousser MG et al. The International Classification of Headache Disorders, 2nd Edition (ICHD-II) - revision of criteria for 8.2 medication-overuse headache. Cephalalgia 25, 460-465 (2005).
124. Bendtsen L, Jensen R, Olesen J. A nonselective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J. Neurol. Neurosurg. Psychiatry 61, 285-290 (1996).
125. Gobel H, Hamouz V, Hansen C et al. Chronic tension-type headache: amitriptyline reduces clinical headacheduration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 59, 241-249 (1994).
126. Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 20, 603-610 (2000).
127. Oguzhanoglu A, Sahiner T, Kurt T, Akalin O. Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches. Cephalalgia 19, 531-532 (1999). • Shows the superiority of amitriptyline in the prevention of TTH and better tolerance of fluoxetine.
128. Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 285, 2208-2215 (2001).
129. Langemark M, Loldrup D, Bech P, Olesen J. Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study. Headache 30, 118-121 (1990).
130. Cohen GL. Protriptyline, chronic tension-type headaches, and weight loss in women. Headache 37, 433-436 (1997).
131. Fogelholm R, Murros K. Maprotiline in chronic tension headache: a double-blind cross-over study. Headache 25, 273-275 (1985).
132. Manna V, Bolino F, Di Cicco L. Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine. Headache 34, 44-49 (1994).
133. Roth T, Rogowski R, Hull S et al. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. Sleep 30, 1555-1561 (2007).
134. Olivares L, Otero E, De la Pena F. [Doxepin in tension headache]. Rev. Invest. Clin. 23, 173-176 (1971).
135. Morland TJ, Storli OV, Mogstad TE. Doxepin in the prophylactic treatment of mixed 'vascular' and tension headache. Headache 19, 382-383 (1979).
136. Langemark M, Olesen J. Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache 34, 20-24 (1994).
137. Holroyd KA, Labus JS, O'Donnell FJ, Cordingley GE. Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation. Headache 43, 999-1004 (2003).
138. Adelman LC, Adelman JU, Von Seggern R, Mannix LK. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 40, 572-580 (2000).
139. Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst. Rev. (3), CD002919 (2005).
140. Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62, 1706-1711 (2004).
141. Fogelholm R, Murros K. Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study. Headache 32, 509-513 (1992).
142. Bettucci D, Testa L, Calzoni S, Mantegazza P, Viana M, Monaco F. Combination of tizanidine and amitriptyline in the prophylaxis of chronic tension-type headache: evaluation of efficacy and impact on quality of life. J. Headache Pain 7, 34-36 (2006).
143. Silberstein SD, Gobel H, Jensen R et al. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia 26, 790-800 (2006).
144. Padberg M, de Bruijn SF, de Haan RJ, Tavy DL. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia 24, 675-680 (2004).
145. Rozen D, Sharma J. Treatment of tension-type headache with botox: a review of the literature. Mt Sinai J. Med. 73, 493-498 (2006).
146. Rollnik JD, Tanneberger O, Schubert M, Schneider U, Dengler R. Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache 40, 300-305 (2000).
147. Evers S. Status on the use of botulinum toxin for headache disorders. Curr. Opin. Neurol. 19, 310-315 (2006).
148. Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of tension-type headache with botulinum toxin: a pilot study. Eur. J. Med. Res. 4, 183-186 (1999).
149. Schulte-Mattler WJ, Krack P. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain 109, 110-114 (2004).
150. Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 41, 658-664 (2001).
151. Ho KY, Tan KH. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review. Eur. J. Pain 11, 519-527 (2007).
152. Bovim G, Sand T. Cervicogenic headache, migraine without aura and tension-type headache. Diagnostic blockade of greater occipital and supra-orbital nerves. Pain 51, 43-48 (1992).
153. Leinisch-Dahlke E, Jurgens T, Bogdahn U, Jakob W, May A. Greater occipital nerve block is ineffective in chronic tension type headache. Cephalalgia 25, 704-708 (2005).
154. Giamberardino MA, Tafuri E, Savini A et al. Contribution of myofascial trigger points to migraine symptoms. J. Pain 8(11), 869-878 (2007).
155. Torelli P, Lambru G, Manzoni GC. Psychiatric comorbidity and headache: clinical and therapeutical aspects. Neurol. Sci. 27(Suppl. 2), S73-S76 (2006).
156. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Prognosis of migraine and tension-type headache: a population-based follow-up study. Neurology 65, 580-585 (2005).
157. Guidetti V, Galli F. Evolution of headache in childhood and adolescence: an 8-year follow-up. Cephalalgia 18, 449-454 (1998).
158. Friedman AP, Finley KM, Graham JR, Kunkle EC, Ostfeld AM, Wolff HG. Classification of Headache. Arch. Neurol. 6, 173-176 (1962).
159. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 8(Suppl. 7), 1-96 (1988).